Emerging drugs for the treatment of wound healing

Bibliography

• Sen CK, Gordillo GM, Roy S, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 2009;17(6):763–71
   PubMed Web of Science ®Google Scholar
• Uzun H, Bitik O, Hekimoglu R, et al. Angiotensin-converting enzyme inhibitor enalapril reduces formation of hypertrophic scars in a rabbit ear wounding model. Plast Reconstr Surg 2013;132(3):361e–71e
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008;453(7193):314–21
   PubMed Web of Science ®Google Scholar
• Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341(10):738–46
   PubMed Web of Science ®Google Scholar
• Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16(5):585–601
   PubMed Web of Science ®Google Scholar
• Yun YR, Won JE, Jeon E, et al. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010;2010:218142
   PubMedGoogle Scholar
• Zakrzewska M, Marcinkowska E, Wiedlocha A. FGF-1: from biology through engineering to potential medical applications. Crit Rev Clin Lab Sci 2008;45(1):91–135
   PubMed Web of Science ®Google Scholar
• Steckelings UM, Henz BM, Wiehstutz S, et al. Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol 2005;153(5):887–93
   PubMed Web of Science ®Google Scholar
• Estes JM, Vande Berg JS, Adzick NS, et al. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 1994;56(3):173–81
   PubMed Web of Science ®Google Scholar
• Hu MS, Maan ZN, Wu JC, et al. Tissue engineering and regenerative repair in wound healing. Ann Biomed Eng 2014;42(7):1494–507
   PubMed Web of Science ®Google Scholar
• Menke NB, Ward KR, Witten TM, et al. Impaired wound healing. Clin Dermatol 2007;25(1):19–25
   PubMed Web of Science ®Google Scholar
• Bloemen MC, van der Veer WM, Ulrich MM, et al. Prevention and curative management of hypertrophic scar formation. Burns 2009;35(4):463–75
   PubMed Web of Science ®Google Scholar
• Asuku ME, Ibrahim A, Ijekeye FO. Post-burn axillary contractures in pediatric patients: a retrospective survey of management and outcome. Burns 2008;34(8):1190–5
   PubMed Web of Science ®Google Scholar
• Ehrlich HP, Desmouliere A, Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994;145(1):105–13
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. US Department of Health and Human Services; Atlanta, GA: 2014
   Google Scholar
• Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014;311(8):806–14
   PubMed Web of Science ®Google Scholar
• World Health Organization. Diabetes: fact sheet 312. November 2014. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/ [Cited 16 November 2014]
   Google Scholar
• World Health Organization. Obesity and overweight: fact sheet 311. August 2014. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/ [Cited 16 November 2014]
   Google Scholar
• Farage MA, Miller KW, Elsner P, Maibach HI. Characteristics of the Aging Skin. Adv Wound Care 2013;2(1):5–10
   PubMedGoogle Scholar
• Hopf HW, Ueno C, Aslam R, et al. Guidelines for the treatment of arterial insufficiency ulcers. Wound Repair Regen 2006;14(6):693–710
   PubMed Web of Science ®Google Scholar
• Robson MC, Cooper DM, Aslam R, et al. Guidelines for the treatment of venous ulcers. Wound Repair Regen 2006;14(6):649–62
   PubMed Web of Science ®Google Scholar
• Whitney J, Phillips L, Aslam R, et al. Guidelines for the treatment of pressure ulcers. Wound Repair Regen 2006;14(6):663–79
   PubMed Web of Science ®Google Scholar
• Steed DL, Attinger C, Colaizzi T, et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen 2006;14(6):680–92
   PubMed Web of Science ®Google Scholar
• Kavitha KV, Tiwari S, Purandare VB, et al. Choice of wound care in diabetic foot ulcer: a practical approach. World J Diabetes 2014;5(4):546–56
   PubMedGoogle Scholar
• Mulder G, Tenenhaus M, D’Souza GF. Reduction of diabetic foot ulcer healing times through use of advanced treatment modalities. Int J Low Extrem Wounds 2014;13(4):335–46
   PubMed Web of Science ®Google Scholar
• Seo SG, Yeo JH, Kim JH, et al. Negative-pressure wound therapy induces endothelial progenitor cell mobilization in diabetic patients with foot infection or skin defects. Exp Mol Med 2013;45:e62
   PubMed Web of Science ®Google Scholar
• Beitz JM, van Rijswijk L. Developing evidence-based algorithms for negative pressure wound therapy in adults with acute and chronic wounds: literature and expert-based face validation results. Ostomy Wound Manage 2012;58(4):50–69
   PubMed Web of Science ®Google Scholar
• Liu R, Li L, Yang M, et al. Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clin Proc 2013;88(2):166–75
   PubMed Web of Science ®Google Scholar
• Margolis DJ, Gupta J, Hoffstad O, et al. Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study. Diabetes Care 2013;36(7):1961–6
   PubMed Web of Science ®Google Scholar
• Regranex (becaplermin) Gel 0.01%. Available from: http://www.regranex.com/index.php [Cited 11 November 2014]
   Google Scholar
• Rodgers K, Verco S, Bolton L, Dizerega G. Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7). Expert Opin Investig Drugs 2011;20(11):1575–81
   PubMed Web of Science ®Google Scholar
• Sen S, Palmieri T, Greenhalgh D. Review of burn research for the year 2013. J Burn Care Res 2014;35(5):362–8
   PubMed Web of Science ®Google Scholar
• Golshan A, Patel C, Hyder AA. A systematic review of the epidemiology of unintentional burn injuries in South Asia. J Public Health (Bangkok) 2013;35(3):384–96
   PubMed Web of Science ®Google Scholar
• World Health Organization. Burns: fact sheet 365. April 2014. Available from: http://www.who.int/mediacentre/factsheets/fs365/en/ [Cited 11 November 2014]
   Google Scholar
• Barajas-Nava LA, Lopez-Alcalde J, Roque i Figuls M, et al. Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database Syst Rev 2013;6:CD008738
   PubMed Web of Science ®Google Scholar
• Lawrence JW, Mason ST, Schomer K, Klein MB. Epidemiology and impact of scarring after burn injury: a systematic review of the literature. J Burn Care Res 2012;33(1):136–46
   PubMed Web of Science ®Google Scholar
• Shih B, Garside E, McGrouther DA, Bayat A. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen 2010;18(2):139–53
   PubMed Web of Science ®Google Scholar
• Wadman M. Scar prevention: the healing touch. Nature 2005;436(7054):1079–80
   PubMed Web of Science ®Google Scholar
• Hu MS, Rennert RC, McArdle A, et al. The role of stem cells during scarless skin wound healing. Adv Wound Care 2014;3(4):304–14
   Google Scholar
• Sheridan RL. Comprehensive treatment of burns. Curr Probl Surg 2001;38(9):657–756
   PubMed Web of Science ®Google Scholar
• Lewis GM, Heimbach DM, Gibran NS. Evaluation of the burn wound: management decisions. In: Herndon DN, editor. Total burn care. 4th edition. Elsevier, Inc; New York: 2012. p. 125–30
   Google Scholar
• Krieger Y, Bogdanov-Berezovsky A, Gurfinkel R, et al. Efficacy of enzymatic debridement of deeply burned hands. Burns 2012;38(1):108–12
   PubMed Web of Science ®Google Scholar
• Singer AJ, Taira BR, Anderson R, et al. The effects of rapid enzymatic debridement of deep partial-thickness burns with Debrase on wound reepithelialization in swine. J Burn Care Res 2010;31(5):795–802
   PubMed Web of Science ®Google Scholar
• Ostlie DJ, Juang D, Aguayo P, et al. Topical silver sulfadiazine vs collagenase ointment for the treatment of partial thickness burns in children: a prospective randomized trial. J Pediatr Surg 2012;47(6):1204–7
   PubMed Web of Science ®Google Scholar
• Sharp NE, Aguayo P, Marx DJ, et al. Nursing preference of topical silver sulfadiazine versus collagenase ointment for treatment of partial thickness burns in children: survey follow-up of a prospective randomized trial. J Trauma Nurs 2014;21(5):253–7
   PubMedGoogle Scholar
• Dai T, Huang YY, Sharma SK, et al. Topical antimicrobials for burn wound infections. Recent Patents Anti-Infect Drug Disc 2010;5(2):124–51
   PubMedGoogle Scholar
• Jayakumar R, Prabaharan M, Sudheesh Kumar PT, et al. Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol Adv 2011;29(3):322–37
   PubMed Web of Science ®Google Scholar
• Millner R, Lockhart AS, Marr R. Chitosan arrests bleeding in major hepatic injuries with clotting dysfunction: an in vivo experimental study in a model of hepatic injury in the presence of moderate systemic heparinisation. Ann R Coll Surg Engl 2010;92(7):559–61
   PubMed Web of Science ®Google Scholar
• Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011;17(1-2):113–25
   PubMed Web of Science ®Google Scholar
• Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 2010;125(2):557–68
   PubMed Web of Science ®Google Scholar
• O’Brien L, Jones DJ. Silicone gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev 2013;9:CD003826
   PubMedGoogle Scholar
• Mustoe TA. Evolution of silicone therapy and mechanism of action in scar management. Aesthetic Plast Surg 2008;32(1):82–92
   PubMed Web of Science ®Google Scholar
• Gauglitz GG. Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol 2013;6:103–14
   PubMedGoogle Scholar
• Muneuchi G, Suzuki S, Onodera M, et al. Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg 2006;40(2):111–16
   PubMed Web of Science ®Google Scholar
• Ud-Din S, Bayat A. Strategic management of keloid disease in ethnic skin: a structured approach supported by the emerging literature. Br J Dermatol 2013;169(Suppl 3):71–81
   PubMedGoogle Scholar
• Qiu Y, Ma G, Lin X, et al. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars. Pediatr Dermatol 2013;30(3):342–7
   PubMed Web of Science ®Google Scholar
• Gold MH, McGuire M, Mustoe TA, et al. Updated international clinical recommendations on scar management: part 2 – algorithms for scar prevention and treatment. Dermatol Surg 2014;40(8):825–31
   PubMed Web of Science ®Google Scholar
• Naeini FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg 2006;32(8):1023–9; discussion 29-30
   PubMed Web of Science ®Google Scholar
• Manca G, Pandolfi P, Gregorelli C, et al. Treatment of keloids and hypertrophic scars with bleomycin and electroporation. Plast Reconstr Surg 2013;132(4):621e–30e
   PubMed Web of Science ®Google Scholar
• Nicoletti G, De Francesco F, Mele CM, et al. Clinical and histologic effects from CO2 laser treatment of keloids. Lasers Med Sci 2013;28(3):957–64
   PubMed Web of Science ®Google Scholar
• Waibel JS, Wulkan AJ, Shumaker PR. Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med 2013;45(3):135–40
   PubMed Web of Science ®Google Scholar
• Akita S, Akino K, Hirano A. Basic Fibroblast Growth Factor in Scarless Wound Healing. Adv Wound Care 2013;2(2):44–9
   PubMed Web of Science ®Google Scholar
• Zhang Z, Michniak-Kohn BB. Tissue engineered human skin equivalents. Pharmaceutics 2012;4(1):26–41
   PubMedGoogle Scholar
• MedMarket Diligence LLC. Worldwide Wound Management, Forecast to 2021: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World. 2013
   Google Scholar
• MediWound Ltd. A study to evaluate the efficacy and safety of nexobrid in subjects with thermal burns. ClinicalTrialsgov 2014. Available from: http://clinicaltrials.gov/show/NCT02148705 [Cited 11 November 2014]
   Google Scholar
• Allegheny Singer Research Institute. Medihoney and santyl for burn injuries (MSBI). ClinicalTrialsgov 2014. Available from: http://clinicaltrials.gov/ct2/show/record/NCT02250183 [Cited 11 November 2014]
   Google Scholar
• Demling RH. Nutrition, anabolism, and the wound healing process: an overview. Eplasty 2009;9:e9
   PubMedGoogle Scholar
• Grotendorst GR, Duncan MR. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 2005;19(7):729–38
   PubMed Web of Science ®Google Scholar
• Ayello EA, Cuddigan JE. Debridement: controlling the necrotic/cellular burden. Adv Skin Wound Care 2004;17(2):66–75; quiz 76-8
   PubMedGoogle Scholar
• Houck JC, Chang CM, Klein G. Isolation of an effective debriding agent from the stems of pineapple plants. Int J Tissue React 1983;5(2):125–34
   PubMedGoogle Scholar
• Pavan R, Jain S, Shraddha Kumar A. Properties and therapeutic application of bromelain: a review. Biotechnol Res Int 2012;2012:976203
   PubMedGoogle Scholar
• Rosenberg L, Krieger Y, Silberstein E, et al. Selectivity of a bromelain based enzymatic debridement agent: a porcine study. Burns 2012;38(7):1035–40
   PubMed Web of Science ®Google Scholar
• Bouten CV, Oomens CW, Baaijens FP, Bader DL. The etiology of pressure ulcers: skin deep or muscle bound? Arch Phys Med Rehabil 2003;84(4):616–19
   PubMed Web of Science ®Google Scholar
• Mustoe TA, O’Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 2006;117(7 Suppl):35S–41S
   PubMed Web of Science ®Google Scholar
• Smith PC. The causes of skin damage and leg ulceration in chronic venous disease. Int J Low Extrem Wounds 2006;5(3):160–8
   PubMedGoogle Scholar
• Wiggins-Dohlvik K, Han MS, Stagg HW, et al. Melatonin inhibits thermal injury-induced hyperpermeability in microvascular endothelial cells. J Trauma Acute Care Surg 2014;77(6):899–905
   Google Scholar
• Schreml S, Szeimies RM, Prantl L, et al. Oxygen in acute and chronic wound healing. Br J Dermatol 2010;163(2):257–68
   PubMed Web of Science ®Google Scholar
• Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000;5(1):40–6
   PubMed Web of Science ®Google Scholar
• Bevan D, Gherardi E, Fan TP, et al. Diverse and potent activities of HGF/SF in skin wound repair. J Pathol 2004;203(3):831–8
   PubMed Web of Science ®Google Scholar
• Kaltalioglu K, Coskun-Cevher S, Tugcu-Demiroz F, Celebi N. PDGF supplementation alters oxidative events in wound healing process: a time course study. Arch Dermatol Res 2013;305(5):415–22
   PubMed Web of Science ®Google Scholar
• Li H, Fu X, Zhang L, et al. Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics. J Surg Res 2008;145(1):41–8
   PubMed Web of Science ®Google Scholar
• Smiell JM, Wieman TJ, Steed DL, et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999;7(5):335–46
   PubMed Web of Science ®Google Scholar
• Gianni-Barrera R, Bartolomeo M, Vollmar B, et al. Split for the cure: VEGF, PDGF-BB and intussusception in therapeutic angiogenesis. Biochem Soc Trans 2014;42(6):1637–42
   PubMed Web of Science ®Google Scholar
• Rykala J, Przybylowska K, Majsterek I, et al. Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables. Pathol Oncol Res 2011;17(4):809–17
   PubMed Web of Science ®Google Scholar
• Liu J, Liu C, Qiu L, et al. Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancer. Diagn Pathol 2014;9:128
   PubMedGoogle Scholar
• van der Veer WM, Niessen FB, Ferreira JA, et al. Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans. Wound Repair Regen 2011;19(3):292–301
   PubMed Web of Science ®Google Scholar
• Cudmore M, Ahmad S, Al-Ani B, et al. VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. Biochem Biophys Res Commun 2006;345(4):1275–82
   PubMed Web of Science ®Google Scholar
• Takeda H, Katagata Y, Hozumi Y, Kondo S. Effects of angiotensin II receptor signaling during skin wound healing. Am J Pathol 2004;165(5):1653–62
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J 2010;24(7):2144–51
   PubMed Web of Science ®Google Scholar
• Min LJ, Cui TX, Yahata Y, et al. Regulation of collagen synthesis in mouse skin fibroblasts by distinct angiotensin II receptor subtypes. Endocrinology 2004;145(1):253–60
   PubMed Web of Science ®Google Scholar
• Baker EA, Leaper DJ. Profiles of matrix metalloproteinases and their tissue inhibitors in intraperitoneal drainage fluid: relationship to wound healing. Wound Repair Regen 2003;11(4):268–74
   PubMed Web of Science ®Google Scholar
• Zaga-Clavellina V, Garcia-Lopez G, Flores-Pliego A, et al. In vitro secretion and activity profiles of matrix metalloproteinases, MMP-9 and MMP-2, in human term extra-placental membranes after exposure to Escherichia coli. Reprod Biol Endocrinol 2011;9:13
   PubMed Web of Science ®Google Scholar
• Colwell AS, Phan TT, Kong W, et al. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation. Plast Reconstr Surg 2005;116(5):1387–90; discussion 91-2
   PubMed Web of Science ®Google Scholar
• Mulder G, Tallis AJ, Marshall VT, et al. Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial. Wound Repair Regen 2009;17(6):772–9
   PubMed Web of Science ®Google Scholar
• Balingit PP, Armstrong DG, Reyzelman AM, et al. NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial. Wound Repair Regen 2012;20(4):482–90
   PubMed Web of Science ®Google Scholar
• Payne WG, Wachtel TL, Smith CA, et al. Effect of amnion-derived cellular cytokine solution on healing of experimental partial-thickness burns. World J Surg 2010;34(7):1663–8
   PubMed Web of Science ®Google Scholar
• Farooqi AA, Rehman ZU, Muntane J. Antisense therapeutics in oncology: current status. Onco Targets Ther 2014;7:2035–42
   PubMed Web of Science ®Google Scholar
• Robert DG, Mark LJ, Jeff J, et al. An antisense oligonucleotide (EXC-001) targeting connective tissue growth factor reduces skin scarring associated with abdominoplasty and reduces CTGF expression. Plast Reconstr Surg 2011;128:45
   Google Scholar
• RXI-109 reduces a key component of dermal scarring, connective tissue growth factor mRNA, in a multidose phase 1 clinical trial. J Am Acad Dermatol 2014;70(5):AB196
   Google Scholar
• Duscher D, Neofytou E, Wong VW, et al. Transdermal deferoxamine prevents pressure-induced diabetic ulcers. Proc Natl Acad Sci USA 2015;112(1):94–9
   PubMed Web of Science ®Google Scholar